Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neurodegenerative diseases
Biotech
Merck KGaA becomes latest partner for Flagship’s Valo Health
Merck and Valo will use the latter’s discovery platform to quickly craft preclinical candidates for newly identified Parkinson's disease targets.
Darren Incorvaia
Nov 20, 2025 6:30am
Voyager sets sail on neuro research trek with Transition Bio
Nov 10, 2025 5:23pm
FDA rejects Biohaven approval request, triggering cost cutting
Nov 5, 2025 4:02am
Roche signs $2B pact to pilot Manifold's shuttles to the brain
Nov 3, 2025 8:45am
Alector halves staff after GSK-partnered antibody fails in ph. 3
Oct 22, 2025 11:23am
2 European biotechs link to tackle neurodegenerative diseases
Oct 20, 2025 8:20am